FDA BIMO Inspection Trends, FY2015-FY2024: Data Atlas
A 2026 data atlas of FDA BIMO inspections by fiscal year, inspected party and classification, with source-deck revisions, denominator rules, observation families and control priorities.
Back to Articles
Articles tagged with “bioequivalence”
Dissolution Testing and Bioequivalence: f2 Similarity, Biowaivers
A 2026 analyst guide to dissolution testing and bioequivalence, covering f2 similarity factor calculation and its statistical limitations, USP apparatus types, BCS biowaiver rules under FDA, EMA, WHO and ICH M9, and IVIVC modeling.